Limbic predominate age-related TDP-43 encephalopathy or LATE is a recently recognized form of dementia that affects memory, thinking and social skills. It mimics Alzheimer's disease or AD (and sometimes co-exists with it), ...
Dec 15, 2022
0
10
Oregon State University scientists have taken a key step toward better understanding neurodegenerative diseases by using a suite of biophysical techniques to learn more about a motor protein whose malfunction is associated ...
Dec 1, 2022
0
43
A number of new neurologic medications for diseases like multiple sclerosis (MS), Parkinson's disease and migraine have received U.S. Food and Drug Administration (FDA) approval over the past decade. However, with most having ...
Nov 30, 2022
0
2
Scientists at the Francis Crick Institute have found that deleting two genes that encode key enzyme proteins (kinases NDR1 and NDR2), impairs the health of neurons and leads to neurodegeneration in young mice as well as in ...
Nov 30, 2022
0
4
Scientists at University of Florida (UF) Scripps Biomedical Research have developed a potential medicine for a leading cause of ALS and dementia that works by eliminating disease-causing segments of RNA. The compound restored ...
Nov 22, 2022
0
725
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has identified a new hallmark of the neurodegenerative disorder, amyotrophic lateral sclerosis (ALS), revealing a likely ...
Nov 22, 2022
0
49
New Caltech research is showing how devices implanted into people's brains, called brain-machine interfaces (BMIs), could one day help patients who have lost their ability to speak. In a new study presented at the 2022 Society ...
Nov 14, 2022
0
8
Muscles waste as a result of not being exercised enough, as happens quickly with a broken limb that has been immobilized in a cast, and more slowly in people reaching an advanced age. Muscle atrophy, how clinicians refer ...
Nov 14, 2022
0
80
Two new studies from Washington University School of Medicine in St. Louis support development of a broadly applicable treatment for neurodegenerative diseases that targets a molecule that serves as the central executioner ...
Oct 27, 2022
0
184
Researchers have made early progress toward a new approach to treating the deadly brain disease amyotrophic lateral sclerosis (ALS): using patients' own immune system T cells.
Oct 21, 2022
0
4
